InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2026-05-26 17:38:01 ET · period of report 2026-05-22 · accession 0001871615-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-05-26 17:38 2026-05-22 GH Freeman Chris Chief Commercial Off M - OptEx $32.86 +24.4K 84.4K +41% +$802.0K
D 2026-05-26 17:38 2026-05-22 GH Freeman Chris Chief Commercial Off S - Sale+OE $118.67 -24.4K 60.0K -29% -$2.90M
D 2026-05-26 17:38 2026-05-22 GH Freeman Chris Chief Commercial Off M - OptEx $0.00 -24.4K 701 -97% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-22 M A 24,406 $32.86 84,440 D — —
2 Common Common Stock 2026-05-22 S D 24,406 $118.67 60,034 D — — (F1) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.55 to $118.97. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
3 Derivative Stock Option (Right to Buy) 2026-05-22 M D 24,406 $0.00 701 D $32.86 · — to 2033-06-09 24,406 Common Stock (F2) This represents a stock option award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 9, 2024 and the remaining 67% of the shares subject to award vests each month during the two-year period thereafter.